Corning and Promega Create Microarray Reagents Deal Targeting Home Brew Market | GenomeWeb

Corning this week announced a new microarray initiative in collaboration with Promega of Madison, Wis.

The two companies will develop and manufacture an integrated set of slides and reagents for the home-brew microarray market, which will be marketed as Pronto Plus Systems.

The strategic alliance follows the glass-slide maker’s entry into the microarray reagent market with a system for validation, printing, and hybridization. This system will be combined with Promega products including SV Total RNA Isolation, ChipShot labeling, and ChipShot cleanup.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.